VT
VIR icon

Vise Technologies’s Vir Biotechnology VIR Stock Holding History

Vise Technologies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,861
Closed -$149K – 368
2023
Q3 		$149K Sell
15,861
-17,022
-52% -$243K 0.04% 324
2023
Q2 		$807K Sell
32,883
-1,888
-5% -$47.4K 0.2% 115
2023
Q1 		$809K Buy
34,771
+4,579
+15% +$117K 0.21% 109
2022
Q4 		$764K Buy
30,192
+8,917
+42% +$219K 0.24% 105
2022
Q3 		$410K Sell
21,275
-2,869
-12% -$72.9K 0.15% 160
2022
Q2 		$615K Buy
+24,144
New +$564K 0.24% 104

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return